While the pandemic is spreading on a global scale, threat actors continue to target government organizations and entities in the pharmaceutical industry.
In early December, the European Medicines Agency (EMA) announced a cyber attack that has targeted it. The EMA did not provide technical details about the attack, nor whether it will have an impact on its operations while it is evaluating and approving COVID-19 vaccines.
“EMA has been the subject of a cyberattack. The Agency has swiftly launched a full investigation, in close cooperation with law enforcement and other relevant entities.” reads the EMA’s announcement.
“EMA cannot provide additional details whilst the investigation is ongoing. Further information will be made available in due course.”
At the time of this writing, it is not clear whether the cyber attack was successful, either when it took place. The agency confirmed to have launched an investigation into the incident.
The European agency plays a crucial role in the evaluation of COVID-19 vaccines across the EU, it has access to sensitive and confidential information, including quality, safety, and effectivity data resulting from trials.
In the last months, security experts reported the surge of the illegal market for Covid-19 vaccines on the Darkweb market.
Recently, Cyble started tracking documents being shared on one of the Russian-speaking forums. The links to the documents have been shared by a newly created profile which was used only for the alleged data leak.
“During the assessment of data, our researchers noticed that multiple confidential files, including MoMs, assessment reports, confidential emails, login portal links and images of its internal pages were accessed and leaked.” reported the analysis published by Cyble.
The experts shared screenshots of the internal email where the portal link was shared, the login page for the portal to access the reports, and images of internal pages.
The documents also include the alleged assessment report of COVID-19 vaccine along with the summary report of drug release and stability.
Below a list of security measures that organizations can adopt to counter the impact of cyberattacks targeting the COVID-19 vaccine supply chain.
If you want to receive the weekly Security Affairs Newsletter for free subscribe here.
(SecurityAffairs – hacking, COVID-19 vaccine)
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.